Home Authors Posts by Jonathan Marino

Jonathan Marino

General Compression, the Massachusetts-based renewable energy company, announced it has closed the first tranche of its $54.5 million Series B round. The company, founded in 2006, did not publicize other details of the financing. Already its first project, with GC investor ConocoPhillips, is underway. This recent round of funding was led by Toronto-based Northwater Capital Management, Inc. Other investors in General Compression include US Renewables Group, Duke Energy, and Serious Change L.P.
David M.V. Barnes will join Imperial Capital as a managing director and head of its financial sponsors coverage team in the investment bank’s LA office. Previously, Barnes had been with investment bank Houlihan Lokey.
Got Our E-mails? Get our e-mails. For FREE! Killing It: Five markets already controlled by Apple FacialRecognitionBook: Facebook expands tech to automatically ID people in photos, arising concerns, prompting untagging from unflattering shots Duh, Losing! Futures headed south as investors continue handwringing
Accel Partners and Meritech Capital Partners led a $50 million investment in YapStone Inc., a provider of electronic payments as a service for property management and other vertical market segments. Financial Technology Partners LP and FTP Securities LLC served as exclusive strategic and financial advisor to YapStone. Specifics on the transaction were not publicized.
Utah-based Social network XYDO.com raised $1.25 million in a seed funding led by EPIC Ventures, the Draper Fisher Jurveston partner fund. Specifics on the funding round were not publicized. Nick Efstratis, a managing director at EPIC Ventures, who will join XYDO's board of directors.
IDG Ventures and Granite Ventures, along with some of the company’s original investors, banded together to provide digital games publisher Telltale Games with a $7 million Series C investment. Phil Sanderson, IDG MD, and Chris Hollenbeck, Managing Director of Granite Ventures, worked on the transaction.
Cyterix Pharmaceutics has landed $9.2 million from The Column Group and SV Life Sciences for its Series A Round. As part of the transaction, Tim Kutzkey, Ph.D., Partner at The Column Group, and Lutz Giebel, Ph.D., Managing Partner at SV Life Sciences, have joined the Cyterix Board of Directors. The company was founded in 2010.
Nasdaq-listed, Washington state-based Concur, the travel and expense management company, will acquire GlobalExpense, a UK competitor, for 12 million pounds sterling plus a potential earn-out of up to 2 million pounds more. Concur was advised by Taylor Wessing LLP on the transaction.
This is Unfortunate: Seems there was a patent suit filed against Skype as its Microsoft deal was closing Good Enough for Lobster: Former SAC trader testifies on “perfect” inside tips Nails Off the Numbers: Dykstra charged with grand theft auto, drug possession No Culprit? German officials can’t say what tipped off E. coli outbreak now
As the global economy sputters and pundits begin bringing up the term “double-dip recession,” VCs that best timed the market may generate the most impressive returns by making exits considered unorthodox for the asset class. Private exchange SecondMarket recently reported that VC firms are among the majority of selling stakeholders now, often selling stakes to […]
pehub
pehub

Copyright PEI Media

Not for publication, email or dissemination